Validation of obesity coding among newly treated nonvalvular atrial fibrillation patients using an integrated electronic medical record and claims database-Reference-Cited by-同舟云学术

Validation of obesity coding among newly treated nonvalvular atrial fibrillation patients using an integrated electronic medical record and claims database

Published:2019-09-28 Issue:2 Volume:36 Page:189-197
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Jain Rahul¹,Watzker Anna¹,Luo Xuemei²,Kang Amiee L.³,Baker Christine L.⁴,Rosenblatt Lisa⁵,Mardekian Jack⁶,Menzin Joseph¹

Affiliation:

1. BHE, Boston, MA, USA;

2. Health Economics & Outcomes Research, Patient Health & Impact, Pfizer Inc., Groton, CT, USA;

3. Worldwide Health Economics & Outcomes Research, Bristol-Myers Squibb Company, Lawrenceville, NJ, USA;

4. Health Economics & Outcomes Research, Patient Health & Impact, Pfizer Inc., New York, NY, USA;

5. US Medical, Bristol-Myers Squibb Company, Lawrenceville, NJ, USA;

6. Statistics, Global Biometrics and Data Management, Pfizer Inc., New York, NY, USA

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2019.1666448

Reference29 articles.

1. Adult Obesity [Internet] [cited 2019 Jan 31]. Available from: https://www.cdc.gov/obesity/data/adult.html

2. Obesity and Overweight [Internet] [cited 2018 Aug 28]. Available from: http://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight

3. National Obesity Rates and Trends [Internet] [cited 2019 Jan 31]. Available from: https://stateofobesity.org/obesity-rates-trends-overview/

4. Worldwide Epidemiology of Atrial Fibrillation

5. Prevalence of Diagnosed Atrial Fibrillation in Adults

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Documentation of the Patient Characteristics Morbid Obesity and Bariatric Surgery in the Hospital Information System and the Influence on the Number of Medication-Related Problems;Annals of Pharmacotherapy;2024-01-24

2. Double, Triple, and Quadruple Jeopardy: Entering Pregnancy With Two or More Multimorbid Diagnoses and Increased Risk of Severe Maternal Morbidity and Postpartum Readmission;Women's Health Issues;2022-11

3. Apixaban Use in Obese Patients: A Review of the Pharmacokinetic, Interventional, and Observational Study Data;American Journal of Cardiovascular Drugs;2022-05-16

4. Effectiveness, safety, and healthcare costs associated with rivaroxaban versus warfarin among venous thromboembolism patients with obesity: a real-world study in the United States;Journal of Thrombosis and Thrombolysis;2022-05-13

5. Comparative Effectiveness and Safety of Direct Oral Anticoagulants vs Warfarin Among Obese Patients With Atrial Fibrillation;CJC Open;2022-04